Role of active surveillance in the management of localized prostate cancer
- PMID: 23271774
- PMCID: PMC3540869
- DOI: 10.1093/jncimonographs/lgs032
Role of active surveillance in the management of localized prostate cancer
Abstract
Active surveillance is an increasingly recognized treatment option for men with low-risk prostate cancer. Despite encouraging evidence for oncologic efficacy and reduction in morbidity, several barriers contribute to the underuse of this management strategy. Consistent selection criteria as well as identification and validation of triggers for subsequent intervention are essential. Incorporation of novel biomarkers as well as advanced imaging techniques may improve surveillance strategies by better defining eligibility as well as improving prompt detection of disease progression.
Similar articles
-
An evidence review of active surveillance in men with localized prostate cancer.Evid Rep Technol Assess (Full Rep). 2011 Dec;(204):1-341. Evid Rep Technol Assess (Full Rep). 2011. PMID: 23126653 Free PMC article. Review.
-
National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancer.Ann Intern Med. 2012 Apr 17;156(8):591-5. doi: 10.7326/0003-4819-156-8-201204170-00401. Epub 2012 Feb 20. Ann Intern Med. 2012. PMID: 22351514 Free PMC article.
-
Active surveillance for prostate cancer: overview and update.Curr Treat Options Oncol. 2013 Mar;14(1):97-108. doi: 10.1007/s11864-012-0221-5. Curr Treat Options Oncol. 2013. PMID: 23318986 Review.
-
Prostate cancer: surgery versus observation for localized prostate cancer.Nat Rev Urol. 2014 Jun;11(6):312-3. doi: 10.1038/nrurol.2014.109. Epub 2014 May 13. Nat Rev Urol. 2014. PMID: 24818851
-
Active surveillance in men with localized prostate cancer: a systematic review.Ann Intern Med. 2012 Apr 17;156(8):582-90. doi: 10.7326/0003-4819-156-8-201204170-00397. Epub 2012 Feb 20. Ann Intern Med. 2012. PMID: 22351515 Review.
Cited by
-
Racial and Ethnic Differences in Prostate Cancer Survivors' Perceived Engagement in Treatment Decision-Making.J Racial Ethn Health Disparities. 2018 Dec;5(6):1273-1283. doi: 10.1007/s40615-018-0475-0. Epub 2018 Mar 7. J Racial Ethn Health Disparities. 2018. PMID: 29516434 Free PMC article.
-
Active surveillance for low-risk prostate cancer in Austria: the online registry of the Qualitätspartnerschaft Urologie (QuapU).Wien Klin Wochenschr. 2017 Jun;129(11-12):375-379. doi: 10.1007/s00508-016-1149-8. Epub 2016 Dec 21. Wien Klin Wochenschr. 2017. PMID: 28004265
-
Evolution of a CDC Public Health Research Agenda for Low-Risk Prostate Cancer.Am J Prev Med. 2015 Dec;49(6 Suppl 5):S483-8. doi: 10.1016/j.amepre.2015.08.016. Am J Prev Med. 2015. PMID: 26590643 Free PMC article.
-
Prostate specific antigen velocity risk count predicts biopsy reclassification for men with very low risk prostate cancer.J Urol. 2014 Mar;191(3):629-37. doi: 10.1016/j.juro.2013.09.029. Epub 2013 Sep 20. J Urol. 2014. PMID: 24060641 Free PMC article.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012 CA Cancer J Clin. 2012. 62(1):10–29 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
